Ranked #2,463 of 8,699 institutional investors
Bronte Capital Management Pty Ltd.
Bondi Junction, C3
$938M
US stock portfolio at live prices · today −$18.1M (−1.90%)
Market closed. Prices as of Nov 20, 8:41 AM ET
- Value at quarter end (Q3 2026)
- $945M
- Change from Q2 2026
- +$56.7M (+6.38%)
- Positions
- 48 · 1 new, 1 sold out
- Filed
- Nov 12, 2026
Not counted in the ranking: call options on $52.0M of stock. $149M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesREGN 16.3%BRK-B 9.33%GOOGL 8.56%AMZN 7.50%IBKR 7.09%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals, Inc. | 165,070 | $152M | 16.3% | Added +2% |
| BRK-B Berkshire Hathaway Inc. | 152,978 | $87.5M | 9.33% | Added +5% |
| GOOGL Alphabet Inc. | 294,414 | $80.3M | 8.56% | Reduced −4% |
| AMZN Amazon.com, Inc. | 273,201 | $70.3M | 7.50% | Added +5% |
| IBKR Interactive Brokers Group, Inc. | 879,553 | $66.5M | 7.09% | Reduced −0% |
| PM Philip Morris International Inc. | 304,952 | $56.9M | 6.06% | Added +2% |
| DIS The Walt Disney Company | 385,659 | $46.4M | 4.94% | Added +7% |
| COF Capital One Financial Corporation | 176,737 | $32.1M | 3.42% | Added +2% |
| FCNCA First Citizens BancShares, Inc. | 14,417 | $31.1M | 3.31% | Added +2% |
| CTVA Corteva, Inc. | 3,094,613 | $25.1M | 2.68% | Added +2% |
| IHG InterContinental Hotels Group PLC | 134,324 | $23.4M | 2.49% | New |
| BF-B Brown-Forman Corporation | 529,314 | $15.9M | 1.70% | Added +14% |
| GHC Graham Holdings Company | 11,653 | $14.6M | 1.56% | Added +2% |
| IBB iShares Biotechnology ETF | 66,212 | $13.5M | 1.44% | Added +1% |
| SHC Sotera Health Company | 806,488 | $13.1M | 1.39% | Added +1% |
| NEM Newmont Corporation | 70,213 | $7.0M | 0.75% | Added +1% |
| NKTR Nektar Therapeutics | 202,057 | $6.6M | 0.70% | Added +2% |
| SQM Sociedad Química y Minera de Chile S.A. | 117,370 | $5.6M | 0.60% | Added +1% |
| ALNY Alnylam Pharmaceuticals, Inc. | 35,708 | $5.3M | 0.56% | Added +1% |
| B Barrick Mining Corporation | 147,771 | $4.9M | 0.53% | Added +1% |
| AUR Aurora Innovation, Inc. | 940,111 | $3.6M | 0.38% | Reduced −57% |
| MDLZ Mondelez International, Inc. | 52,613 | $3.5M | 0.37% | Reduced −1% |
| TYL Tyler Technologies, Inc. | 8,454 | $3.4M | 0.36% | Added +2% |
| IJR iShares Core S&P Small-Cap ETF | 23,419 | $3.2M | 0.34% | Added +2% |
| PCTY Paylocity Holding Corporation | 18,209 | $3.2M | 0.34% | Added +2% |
| RVMD Revolution Medicines, Inc. | 18,977 | $3.0M | 0.32% | Added +1% |
| BF-A Brown-Forman Corporation | 96,294 | $3.0M | 0.32% | Added +1% |
| BBWI Bath & Body Works, Inc. | 144,529 | $2.7M | 0.29% | Added +1% |
| TPB Turning Point Brands, Inc. | 41,036 | $2.0M | 0.21% | Added +1% |
| NICE NICE Ltd. | 16,521 | $1.4M | 0.15% | Added +1% |
| OLED Universal Display Corporation | 10,292 | $854K | <0.1% | Added +0% |
| VRSK Verisk Analytics, Inc. | 2,667 | $535K | <0.1% | Reduced −1% |
| PEPG PepGen Inc. | 17,776 | $70K | <0.1% | Unchanged |
| TMCI Treace Medical Concepts, Inc. | 15,577 | $68K | <0.1% | Unchanged |
| ANTX AN2 Therapeutics, Inc. | 10,895 | $57K | <0.1% | Unchanged |
| ENVX Enovix Corporation | 41,765 | $54K | <0.1% | Unchanged |
| CMRC Commerce.com, Inc. | 10,278 | $33K | <0.1% | Unchanged |
| PACB Pacific Biosciences of California, Inc. | 17,881 | $31K | <0.1% | Unchanged |
| ALEC Alector, Inc. | 11,758 | $27K | <0.1% | Unchanged |
| CCCC C4 Therapeutics, Inc. | 10,349 | $25K | <0.1% | Unchanged |
| FATE Fate Therapeutics, Inc. | 21,740 | $22K | <0.1% | Unchanged |
| SEER Seer, Inc. | 15,109 | $21K | <0.1% | Unchanged |
| ALXO ALX Oncology Holdings Inc. | 18,095 | $18K | <0.1% | Unchanged |
| BLND Blend Labs, Inc. | 19,247 | $17K | <0.1% | Unchanged |
| NBP NovaBridge Biosciences | 11,192 | $10K | <0.1% | Unchanged |
| CHRS Coherus Oncology, Inc. | 15,262 | $6K | <0.1% | Unchanged |
| MIST Milestone Pharmaceuticals Inc. | 14,390 | $6K | <0.1% | Unchanged |
| ABOS Acumen Pharmaceuticals, Inc. | 10,716 | $2K | <0.1% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| GOSS Gossamer Bio, Inc. | 847 | $10K |